SCHEMBL3645277

SCHEMBL3645277

Cc1nc(C(=O)N(C)CCN)c(-c2ccccc2)s1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 6/20 0.50
HCRTR2 O43614 6/20 0.50
CHEK1 O14757 1/20 0.46
ALOX5 P09917 1/20 0.46
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PIN1 Q13526 3/20 0.41
CSNK2A2 P19784 1/20 0.40
KDR P35968 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
PTGS1 P23219 2/20 0.40
PTGS2 P35354 2/20 0.40
CYP3A4 P08684 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3647475 0.88 HCRTR1 (0.51) HCRTR1HCRTR2PTGS2
SCHEMBL3645275 0.85 PIN1 (0.58) HCRTR1HCRTR2ALOX5HPGDSMN1; SMN2
SCHEMBL3644934 0.83 HCRTR1 (0.52) HCRTR1HCRTR2ALOX5PIN1CYP3A4
SCHEMBL3648178 0.82 HCRTR1 (0.51) HCRTR1HCRTR2ALOX5HPGDSMN1; SMN2
SCHEMBL3645099 0.82 HCRTR1 (0.51) HCRTR1HCRTR2ALOX5HPGDSMN1; SMN2
SCHEMBL3649840 0.82 HCRTR1 (0.48) HCRTR1HCRTR2
SCHEMBL3640113 0.81 HCRTR1 (0.50) HCRTR1HCRTR2ALOX5HPGDSMN1; SMN2
SCHEMBL3646734 0.81 HCRTR1 (0.55) HCRTR1HCRTR2ALOX5HPGDSMN1; SMN2
SCHEMBL3640642 0.80 HCRTR1 (0.49) HCRTR1HCRTR2ALOX5CYP3A4
SCHEMBL3640315 0.79 HCRTR1 (0.60) HCRTR1HCRTR2PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP claimed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO claimed
EP-2188282-B1 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2013-01-23 EP disclosed
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP disclosed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO disclosed